ライフサイエンスコーパス: peptide fragment

1 hic secreted APPalpha (sAPPalpha) and the P3 peptide fragment.

2 expression of a betaarr1 C-terminal-derived peptide fragment.

3 in the hydrolysis of polypeptides into small peptide fragments.

4 e of proIAPP in detail by analyzing a set of peptide fragments.

5 ent for intact proteins rather than degraded peptide fragments.

6 uently requires proteolysis of proteins into peptide fragments.

7 ire processing of native proteins into short peptide fragments.

8 hat is based on the coupling of glycopeptide/peptide fragments.

9 as obtained through N-terminal sequencing of peptide fragments.

10 hod for the total synthesis of proteins from peptide fragments.

11 d comparative mass spectrometric analysis of peptide fragments.

12 leading to the formation of Abeta and Abeta peptide fragments.

13 ell as circulating N-terminal and C-terminal peptide fragments.

14 ave studied the characteristics of these two peptide fragments.

15 half by mapping the photocovalently modified peptide fragments.

16 ed to completely prevent generation of small peptide fragments.

17 '-phosphorylated pentanucleotides containing peptide fragments.

18 ased upon single-stranded DNA scaffolding of peptide fragments.

19 only a few structures of oligomers formed by peptide fragments.

20 ro, staphopain B degraded LL-37 into shorter peptide fragments.

21 e semisynthesis via the chemical ligation of peptide fragments.

22 ti-apoptotic N1 and the scrapie-resistant C1 peptide fragments.

23 hat generate the pathogenic or nonpathogenic peptide fragments.

24 where it cleaves food proteins into smaller peptide fragments.

25 ation may prevent the formation of cytotoxic peptide fragments.

26 erform native chemical ligation (NCL) of two peptide fragments.

27 nize the organismal origin of unknown DNA or peptide fragments.

28 bn-N) and the TRAP (tyrosine-rich amelogenin peptide) fragments.

29 We have used the activation peptide fragment 1.2 (F12), a ligand for anion-binding e

30 The molecular conformation of peptide fragment 105-115 of transthyretin, TTR(105-115),

31 Gastrin-releasing peptide fragment 14-27 and gastrin 17, regulatory molecu

32 One peptide fragment (19 amino acids) spans IGF-I residues 7

33 Synthesis and coupling of the individual peptide fragments [34 + 35 --> 51] followed by macrocycl

34 Preabsorption of the antiserum with metastin peptide fragment (45-54)-NH2 (1 microg/ml) resulted in n

35 um directed against the synthetic C-terminal peptide fragment (47-73), irBC was detected in the mouse

36 sing amino acid sequences derived from Csp24 peptide fragments, a full-length cDNA was cloned and sho

37 d chromatography fraction revealed two alpha-peptide fragments (alpha128-alpha139) and a heme moiety

38 Peptide fragment analysis of the diagnostic peak in amni

39 esulted in the cleavage of the MB containing peptide fragment and caused a decrease in electrical sig

40 ucture of Naa50p bound to a native substrate peptide fragment and CoA.

41 d PKC-stimulated phosphorylation of the same peptide fragments and comigration of PKC-stimulated phos

42 We have identified Mtb-specific peptide fragments and developed a method to rapidly quan

43 corresponding to the carbohydrate-containing peptide fragments and large and small trypsin fragments

44 with MALDI-TOF mass spectrometry analysis of peptide fragments and peptide microsequencing, indicates

45 of the MHC class I heavy chain, an antigenic peptide fragment, and beta2-microglobulin (beta2m).

46 sequence patterns, distinct from non-binding peptide fragments, and multi-millions of binding and non

47 -expressed T-cell receptors (TCRs) recognize peptide fragments (antigens) of pathogens bound to major

48 h analyses typically assume that a protein's peptide fragments are observed with equal likelihood, on

49 Such 10 purified peptide fragments are screened against sera from patient

50 -isotope tags and fragmented, and the tagged peptide fragments are separated by liquid chromatography

51 s in the fluorescence intensity of a labeled peptide fragment as well as a decrease in solution pH as

52 measuring the oxidation extent of different peptide fragments as a function of microwave power.

53 The resulting peptide fragment assembles into fibrils promoting the fo

54 mechanisms by which beta-amyloid (Abeta), a peptide fragment believed to contribute to Alzheimer's d

55 dentify differentially abundant proteins and peptide fragments between age groups.

56 ld SPI forms large ions identified as common peptide fragments bound to either Fmoc or the surface li

57 effective in preliminary searches for C-PTH peptide fragments, but the use of high laser power limit

58 ation of surface labeled and biotin captured peptide fragments by LC/MS/MS.

59 Here we show that peptide fragments can be exchanged by a chemoselective a

60 observations that the amino acid sequence of peptide fragments can change upon activation.

61 vealed that the CB1 C-terminal juxtamembrane peptide fragment CB1-(401-417) can directly activate the

62 nhardtii caltractin (CRC-C) and a 19 residue peptide fragment comprising the putative cdc31p-binding

63 ctional characteristics of template-directed peptide fragment condensation reactions in neutral aqueo

64 offer the promise of using this chemistry in peptide fragment condensations to produce modified pepti

65 Use of peptide fragments confirm that PrP(92-96) and PrP(107-11

66 LC/MS/MS analysis of the peptide fragment confirmed adduction of either Tyr 127 o

67 receptor, while [ (125)I]IAC44 was found in peptide fragments consistent with labeling of both SBDLI

68 These resistant Ara h 2 peptide fragments contain intact IgE-binding epitopes an

69 This peptide fragment contained a sequence that corresponded

70 in its amino acid sequence and that a TcSSS peptide fragment containing a sequence homologous to a b

71 and RGS16 incorporated [3H]palmitate into a peptide fragment containing Cys-98, a highly conserved c

72 Moreover, we show that a CTD peptide fragment containing His-447, His-449, and Cys-45

73 A 5-kDa tryptic digest peptide fragment containing six acidic residues at posit

74 o signal, whereas the enzymatically produced peptide fragment containing the above sequence showed th

75 the label was recovered in the COOH-terminal peptide fragment containing the engineered cysteine.

76 Finally, a short peptide fragment containing the NCX1-Met(369) cleavage s

77 We identified six peptide fragments containing 12 phosphorylated residues

78 718 and 1831, corresponding to the unlabeled peptide fragments containing the active site Tyr411 resi

79 fibrils are built by modifying the synthetic peptide fragment corresponding to residues 105-115 of th

80 Examination of peptide fragments corresponding to residues 1 to 13 reve

81 natured F30H-G(B1) is more extensive than in peptide fragments corresponding to the beta1-beta2, alph

82 d anti-hinge antibodies were generated using peptide fragments corresponding to the endostatin region

83 tion of vectors that drive the expression of peptide fragments corresponding to their binding domains

84 cortactin Src homology 3 (SH3) domain with a peptide fragment derived from a cDNA encoding a region o

85 We previously discovered a peptide fragment derived from A46 termed VIPER (Viral In

86 tal surface with REDOR NMR show that, in the peptide fragment derived from the N-terminal 15 amino ac

87 fold enhancement to the detection of tryptic peptide fragments derived from in-gel digests.

88 f high-resolution structures of CaM bound to peptide fragments derived from ion channels, there is no

89 are made up of multiple naturally occurring peptide fragments derived from semen.

90 A set of peptide fragments derived from the headpiece were also c

91 ancing activity parallels the degradation of peptide fragments derived from the semenogelins (SEMs),

92 the Ru label, whereas binding of the cleaved peptide fragment devoid of Ru label reduced the ECL sign

93 to P37-42, OspA, GT, or six overlapping Arp peptide fragments did not.

94 Cu(I) ligation by a Cys-rich domain peptide fragment drives the cooperative assembly of a po

95 measure the molecular weights of the tryptic peptide fragments (e.g., peptide mass mapping) and parti

96 rabbit antiserum raised against a synthetic peptide fragment encoding the unique C terminus revealed

97 ing the Rosetta fragment picker for accurate peptide fragment ensemble generation, the PIPER docking

98 uence patterns between intra-protein binding peptide fragments exist, they can be extracted using a d

99 vity to Scl-70 and 8 overlapping recombinant peptide fragments (F1-F8) that span the human topo I mol

100 the peptide mass fingerprint (MALDI-TOF) and peptide fragment fingerprinting (MALDI LIFT-TOF/TOF) spe

101 Peptide fragments for mass spectrometry analysis were ob

102 A key observation was that a peptide fragment formed of the first N-terminal 15 resid

103 on these regions, we focused on an antigenic peptide fragment from a disulfide bridge-bounded region

104 In contrast, a peptide fragment from domain C reduced the number of syn

105 PAPf39, a 39-residue peptide fragment from human prostatic acidic phosphatase

106 anic molecule (fluorescein), a 12 amino acid peptide fragment from the C-terminus of beta-catenin, th

107 PAPf39 is a 39-residue peptide fragment from the sequence of human prostatic ac

108 Titration of a peptide fragment from the yeast Kar1p protein to the iso

109 xpensive methodology to generate fluorescent peptide fragments from a parent sequence with diverse ch

110 nd multi-millions of binding and non-binding peptide fragments from currently available protein X-ray

111 tration calorimetry to investigate synthetic peptide fragments from different domains of the full-len

112 Biotinylated peptide fragments from labeled proteomes are captured an

113 Sequencing of peptide fragments from MtmB by Edman degradation and mas

114 In semen, proteolytic peptide fragments from prostatic acid phosphatase can fo

115 Peptide fragments from standard protein digests of bovin

116 Host cells also display peptide fragments from the host's own proteins.

117 vations by examining a series of overlapping peptide fragments from the human and rodent sequences.

118 tact tetramer, and (3) release of C-terminal peptide fragments from the intact complex.

119 Three phosphoThr peptide fragments from the kinase domain of CLV1 or BAK1

120 proteins and/or an LC-MS analysis of tryptic peptide fragments generated after the oxidation reaction

121 Peptide fragments generated by collagenolysis, and the c

122 taL-crystallin was higher in the presence of peptide fragments generated from oxidized and trypsin-di

123 MALDI MS/MS analysis of peptide fragments generated from the large-diameter core

124 , isoaspartic, and aspartic acid isoforms of peptide fragments generated using trypsin.

125 erefore been necessary, for instance, on the peptide fragment GNNQQNY7-13 of yeast prion protein Sup3

126 Structural analysis of peptide fragments has provided useful information on the

127 l crystal structures of skeletal muscle RyR1 peptide fragments have been solved, but these cover less

128 The intra-protein binding peptide fragments have specific and intrinsic sequence p

129 he side chain of the self-assembling amyloid peptide fragment HHQALVFFA to give ccAQLVFFA.

130 with CD and 1D NMR studies of the 21-residue peptide fragment (HP21) derived from HP36 have shown tha

131 s work, for the first time, four human C-PTH peptide fragments, hPTH(34-84), hPTH(37-84), hPTH(38-84)

132 The four C-PTH peptide fragments identified in plasma samples from pati

133 les protein sequences from their constituent peptide fragments identified on short reads.

134 oth cell types, and amino acid sequencing of peptide fragments identified the same protein, histone H

135 antibodies against GB-generated centromeric peptide fragments identify a distinct clinical subset.

136 hat inhibit the recruitment of a coactivator peptide fragment in in vitro biochemical assays (IC(50)

137 simultaneous detection of PTHrP isoforms and peptide fragments in 30 min.

138 signature for identifying inhibitor-modified peptide fragments in complex mass spectrometry data.

139 esults suggest novel roles for ATIII-derived peptide fragments in host defense.

140 d approaches were capable of detecting C-PTH peptide fragments in human plasma at <10 pmol/L.

141 , we identified over one dozen APP-generated peptide fragments in wild-type yeast (PRE1PRE2) and over

142 Tryptic peptides fragment in ion trap tandem mass spectrometry t

143 on program, it was observed that some cyclic peptides fragmented in unexpected ways resulting in the

144 eave chromogranin A into biologically active peptide fragments, including catestatin, which inhibits

145 We used recombinant MMP12 peptide fragments, including its catalytic domain, CTD,

146 ry/mass spectrometry analysis on the tryptic peptide fragments indicates that the 3-fluorosialyl moie

147 reached by using only seven short synthetic peptide fragments, instead of the 155 non-overlapping 15

148 1 at multiple sites to release transmembrane peptide fragments into the aqueous solvent.

149 ecursors, presentation requires transport of peptide fragments into the ER, but the nature of the cyt

150 site-specific integration of amino acids and peptide fragments into the homodetic cyclic peptide arch

151 nt ions to probe the components of gas-phase peptide fragment ion isomers.

152 ed by a diagnostic mass shift in one or more peptide fragment ions (for example, phosphorylation).

153 s into unused spectral space where no native peptide fragment ions exist.

154 ion and quantification of twinned peaks from peptide fragment ions in MS(2) spectra.

155 aining reagents for shifting mass defects of peptide fragment ions was systematically investigated, t

156 The ASA method successfully distinguishes peptide fragment ions with and without an FIMDL group an

157 well as for facile mass spectral analysis of peptide fragment ions with increased mass defects.

158 ctra included singly protonated peptide ion, peptide fragment ions, and peaks characteristic of the s

159 dentification of these separated proteins or peptide fragments is typically achieved by mass spectrom

160 Sequencing of peptide fragments isolated from [(3)H]CMPI-photolabeled

161 ce with the mixed GAG glycosylation of agrin peptide fragments, it was found that recombinant and in

162 e (TDP1) is a DNA repair enzyme that removes peptide fragments linked through tyrosine to the 3' end

163 type glycopeptide fraction revealed Asn-732 peptide fragments linked to the sulfoquinovose-containin

164 that exist in vertebrates, presenting small peptide fragments, lipid molecules, or small molecule me

165 ing and assembling the native structure from peptide fragments, local structures first.

166 for DnaK, examined via a short 13-mer apoMb peptide fragment matching the binding site sequence, dis

167 f spermatogenesis suggests that this laminin peptide fragment may serve as a contraceptive in male ra

168 The specific binding between short peptide fragments may provide an important driving force

169 inally, intracellular application of the MIF peptide fragment MIF-(50-65), which harbors the thiol ox

170 he biotinylated peptides and analysis of the peptide fragment mixture by nanospray liquid chromatogra

171 sis of the pepsin-induced fibrils implicates peptide fragments (named H) consisting of the 13 or 15 N

172 Furthermore, we identified several new peptide fragments (neopeptides) present in aged tendons,

173 Application of the active peptide fragment NT8-13 produced synaptic depression tha

174 gen-associated molecular patterns, including peptide fragment of bacterial flagellin (flg22) or trans

175 It was shown that a 45-mer peptide fragment of collagen type II with five hydroxypr

176 Using in vitro systems, we have identified a peptide fragment of gankyrin, 176LHLACDEERN185, which is

177 Previously, we have identified a small peptide fragment of IL-2 that was found to contain the e

178 reatment of MeCP2 mutant mice with an active peptide fragment of Insulin-like Growth Factor 1 (IGF-1)

179 as reinhardtii centrin for calcium and for a peptide fragment of Kar1p using CD, fluorescence, and NM

180 that the binding mode and stoichiometry of a peptide fragment of NDR (NDR(62-87)) is the same as for

181 location of PPAR-gamma is blocked by a short peptide fragment of NOC that inhibits its physical inter

182 bound to a 15 amino acid residue N-terminal peptide fragment of p85.

183 I), an amyloid fibril formed from a cationic peptide fragment of prostatic acidic phosphatase (PAP),

184 Adult SJL mice injected i.p. with a peptide fragment of proteolipid protein (a candidate aut

185 One peptide fragment of semenogelin I, termed SG-1, was puri

186 we report the high-resolution structure of a peptide fragment of the amyloidogenic protein transthyre

187 Introduction of the C-terminal peptide fragment of the ArPIKfyve-ArPIKfyve contact site

188 Dialysis of a small peptide fragment of the auxiliary beta4 Na(+) channel su

189 The peptide fragment of the channel is based on a conserved

190 f cancer marker protein Ki67 (Ki67FHA) and a peptide fragment of the hNIFK signaling protein.

191 This study indicates that a small peptide fragment of the human PEDF molecule could be eng

192 A peptide fragment of the I-II loop was purified from bact

193 assessed whether administration of a soluble peptide fragment of the NgR (sNgR) that binds to and blo

194 An enzymatically inactive peptide fragment of the PIKfyve catalytic domain was fou

195 myloid fibrils formed from a self-assembling peptide fragment of the protein prostatic acid phosphata

196 A recombinant peptide fragment of the SMRT (silencing mediator for ret

197 NMR studies showed that a peptide fragment of the V2R C terminus containing the RG

198 d VEGF-A binding in the NRP1 b1 domain and a peptide fragment of VEGF-A was shown to bind at the same

199 haracterize separation between amyloidogenic peptide fragments of alpha-synuclein.

200 of DCs to internalize, degrade, and express peptide fragments of antigenic proteins on their surface

201 s were substantially inhibited by N-terminal peptide fragments of Anxa2 or anti-Anxa2 antibodies.

202 CD8(+) T cells recognize peptide fragments of endogenously synthesized antigens o

203 uence curvature sensing and explores whether peptide fragments of even shorter length can function as

204 ss spectrometric analysis of the proteolytic peptide fragments of IN.

205 We have synthesized nine peptide fragments of NDP-MSH, deleting N- and C-terminal

206 tagonists of NgR derived from amino-terminal peptide fragments of Nogo-66.

207 roups by those measured by Kuhlman et al. in peptide fragments of NTL9.

208 pansion, followed by exposure to overlapping peptide fragments of PE38 and an IL-2 ELISpot assay to m

209 cyte Antigen (HLA) Class I molecules bind to peptide fragments of proteins degraded inside the cell a

210 ificant reactions of the monochloramine with peptide fragments of proteins that are associated with c

211 gators have therefore preferred to work with peptide fragments of PrP, suggesting that these peptides

212 Peptide fragments of self-proteins bound to major histoc

213 betic (NOD) mice, repeated administration of peptide fragments of target antigens in incomplete Freun

214 sequencing of two cyanogen bromide-generated peptide fragments of the 43-kDa trans-factor revealed co

215 ionization mass spectrometry identified two peptide fragments of the alphaB crystallin Walker-B moti

216 state: the protein in 6 M urea, and unfolded peptide fragments of the protein in water.

217 Previous studies have shown that synthetic peptide fragments of the PrP sequence corresponding to r

218 The tryptic peptide fragments of this phosphoprotein were sequenced

219 Importantly, expression of recombinant peptide fragments of wild-type SOD1 in cultured cells al

220 the modified ubiquitin and isomeric glycated peptides (fragments of bovine serum albumin (BSA)).

221 Loading of antigenic peptide fragments on major histocompatibility complex cl

222 on, expression of a dominant negative mutant peptide fragment or injection of a function-blocking ant

223 allows the controlled production of typical peptide fragments or elemental reporter ions informing a

224 gamma-chains of fibrin and the appearance of peptide fragments over time were assessed by polyacrylam

225 he CD8(+) T-cell surface interact with short peptide fragments (p) bound to MHC class I molecules (pM

226 In addition, the peptide fragment PAMP(12-20) inhibits tumor cell-induced

227 Recently, a peptide fragment (PAP(248-286)) has been isolated from s

228 On uPA activation, NIR-NFP releases peptide fragments (PEG(54)-BK(NIR664)SGR-CONH(2)) that c

229 Full-length and conserved C-terminal delta peptide fragments permeabilize the plasma membranes of n

230 olyglutamine-expanded huntingtin protein and peptide fragments (polyQ-Htt).

231 CTLs recognize short peptide fragments presented in association with MHC clas

232 udy, we provide evidence that the C-terminal peptide fragment produced by caspase cleavage inhibits t

233 Low molecular weight protamine (LMWP) is a peptide fragment produced in our laboratory from enzymat

234 Immunization with an amyloid beta-peptide fragment reduces learning and memory impairments

235 These results indicate that urinary peptide fragments reflect changes in expression of intac

236 scopic and mass spectrometric studies of the peptide fragments resulting from tryptic digestion of Ka

237 nce liquid chromatographic separation of the peptide fragments resulting from tryptic digestion of re

238 and structure of microbial communities using peptide fragment sequences extracted from metagenomic se

239 Both VGF and pro-SAAS are cleaved into peptide fragments, several of which are biologically act

240 em, it is generally assumed that angiotensin peptide fragments shorter than angiotensins II and III,

241 ts on the full alphatalpha motif and its two peptide fragments show that interhelical tertiary contac

242 ons followed by MALDI-TOF MS analysis of the peptide fragments showed these 47 kDa species to be CRP

243 A serine-rich peptide fragment spanning residues 221 to 240 was highly

244 e species include full-length SOD1 proteins, peptide fragments, stable oligomers and ubiquitinated en

245 ) NMR study of the fibrils formed by a small peptide fragment, structural details of beta(2)m fibrils

246 cross-linking and co-immunoprecipitation of peptide fragments suggested an inter-subunit N- and C-te

247 tive did not identify any covalently labeled peptide fragments, suggesting that the phenylazido side

248 ansfected HEK-293 cells revealed that a CFTR peptide fragment that binds AMPK (CFTR-1420-57) disrupte

249 an be used as a template to design a minimal peptide fragment that can be used as a drug against Rho-

250 A crystal structure, solved using a peptide fragment that contained residues 12 to 60, depic

251 e the solution structure of the Abeta(21-30) peptide fragment that may be relevant for understanding

252 A peptide fragment that spans the IQ motif of p68 strongly

253 otease digestion of the complex, generated a peptide fragment that was bound to the SG promoter.

254 ides/proteins such as protamine into smaller peptide fragments that are not detected by the sensing f

255 ty of SagA is required and generates muramyl-peptide fragments that are sufficient to protect C. eleg

256 oach involves the digestion of proteins into peptide fragments that can be detected and sequenced wit

257 radation, inflammation and invasion liberate peptide fragments that can subsequently interact with ce

258 th or without CKI-alpha depletion identified peptide fragments that corresponded to the region locate

259 osurvival signaling or generate proapoptotic peptide fragments that help to execute the death program

260 Consistent with this model, peptide fragments that included the membrane binding reg

261 arboxyl-terminal parathyroid hormone (C-PTH) peptide fragments that may be present at only picomolar

262 acquisition of approximately 100 overlapping peptide fragments that redundantly cover the 243-residue

263 that barnase can be split into two inactive peptide fragments, that when co-expressed can complement

264 the C-terminal acyl donor and using smaller peptide fragments, the Cys(29)-Gly(77) glycopeptide doma

265 derived from automatic Edman degradation of peptide fragments, the SmCI sequence was fully character

266 Alanine ligation was used to assemble four peptide fragments, themselves prepared by solid phase pe

267 are generally characterized through tryptic peptide fragments, this paper reports a method for the i

268 ies via the deactivation of the SrtA-excised peptide fragment through diketopiperazine (DKP) formatio

269 ble to effectively stabilize the problematic peptide fragment through the attachment of cleavable arg

270 used to probe the intrinsic fluorescence of peptide fragments through "deep-UV" excitation of aromat

271 omochiral products from a racemic mixture of peptide fragments through a chiroselective autocatalytic

272 acyl-enzyme intermediate linking one of the peptide fragment to a catalytic subunit of the proteasom

273 MyBP-C (cMyBP-C), we added human N-terminal peptide fragments to human and rodent skinned ventricula

274 A peptide fragment, UQ(1-51), encompassing residues 1 to 5

275 ex with the human receptor and a coactivator peptide fragment using x-ray crystallography at 1.9-A re

276 However, the challenging exchange of peptide fragments using a dynamic covalent peptide bond

277 A major peptide fragment was detected at m/z 1088 by a MALDI-TOF

278 increase in the relative intensities of the peptide fragments was achieved, which led to the identif

279 ity relationship of human LL-37, a series of peptide fragments was designed.

280 aterial throughput and convergency, the five peptide fragments were assembled into the native ATAD2 b

281 ch protein digest and the number of detected peptide fragments were compared with conventional MALDI

282 the peptide bonds of BSA were hydrolyzed and peptide fragments were desorbed from the surface of gold

283 The same peptide fragments were formed when the lead peptide was

284 Three distinct p21 derived peptide fragments were found to bind to DAPK; however, t

285 Peptide fragments were fractionated by reverse-phase hig

286 ll-length Gag-p24 protein, and the resulting peptide fragments were identified by mass spectrometry.

287 ng MALDI-TOF MS, and 102 out of 153 possible peptide fragments were identified giving a sequence cove

288 digested with chymotrypsin, and the modified peptide fragments were isolated and characterized as 6-h

289 C-PTH peptide fragments were isolated from plasma samples by i

290 ed caspase-3 in vitro, 13- and 17-kDa capsid peptide fragments were observed and were predicted by al

291 th trypsin and endoproteinase Asp-N, and the peptide fragments were purified by high performance liqu

292 le GFAP- and MBP-immunoreactive proteins and peptide fragments were seen, and many of them were also

293 Nonglycosylated peptide fragments were susceptible to complete Pronase d

294 istinct proteasomal degradation patterns and peptide fragments were unique to either mature DC or act

295 A longer peptide fragment which contains the first and second hel

296 ) is a naturally occurring 40- or 42-residue peptide fragment with a primary role in Alzheimer's dise

297 a recombinantly produced PIKfyve FYVE domain peptide fragment with PtdIns 3-P-containing liposomes th

298 B), specifically and rapidly hydrolyzes stem peptide fragments with a free N-terminus.

299 omic sequence collections revealed groups of peptide fragments with a relatively high abundance and n

300 N-terminally formylated signal peptide fragments with variable sequence and length acti